N/A
N=8,565
Evidence-Based Colorectal Cancer Screening for the Uninsured
Colorectal Cancer
Bottom Line
View on ClinicalTrials.gov: NCT01946282 ↗Enrolled (actual)
8,565
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: FIT Completion Among Patients Offered Any Incentive vs. Outreach Alone Each Year — 2391; 738; 1255; 394 Participants — p=0.59
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- FIT Invitation Only (Other); FIT plus $5 Incentive (Other); FIT plus $10 Incentive (Other)
- Age
- Adult · 50+ yrs
- Sex
- All
- Sponsor
- University of Texas Southwestern Medical Center
- Primary completion
- Apr 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY FIT Completion Among Patients Offered Any Incentive vs. Outreach Alone Each Year |
2391; 738; 1255; 394; 856; 281 | 0.59 |
| SECONDARY FIT Completion for Groups Offered $5 vs. Outreach Alone, $10 vs. Outreach Alone, and $5 vs. $10 Incentive |
392; 346; 2379; 210; 184; 1248 | 0.070 |
Summary
Through this program, the investigators will test a systematic colon cancer screening outreach strategy for increasing screening completion among uninsured patients, not up-to-date with screening. The intervention will consist of mailed screening invitations, with processes such as phone reminders to promote screening and evidence based follow up. All patients will be randomly assigned to receive mailed invitations to complete a home fecal immunochemical test (FIT). Some patients will be randomly assigned to receive a small financial incentive on completion of FIT testing.
Eligibility Criteria
Inclusion Criteria
- Age 50-64.
- Uninsured, but participants in John Peter Smith Health System (JPS) medical assistance program for the uninsured.
- One or more visits to a JPS primary care clinic within a year.
- Not up-to-date with colorectal cancer screening.
Exclusion Criteria
- Patients with a history of Colorectal Cancer or colon resection, no address and/or phone number on file, or who are incarcerated will be excluded.
Data sourced from ClinicalTrials.gov (NCT01946282). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.